tiprankstipranks
VYNE Therapeutics (VYNE)
NASDAQ:VYNE
US Market

VYNE Therapeutics (VYNE) Stock Investors

1,799 Followers
Based on 720,935 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VYNE
On average, investors allocate 2.03% of their portfolios to VYNE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VYNE

3.3%
Last 7
Days
4.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VYNE, out of 720,935 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VYNE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.03%
$1.71
Based on the activity of 13,516 investors who made their portfolios public
The table shows changes in VYNE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VYNE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
7.10%
+0.48%
+3.19%
36.07B
Consumer Cyclical
ChargePoint Holdings
3.95%
-0.94%
-1.95%
802.61M
Consumer Cyclical
Marathon Digital Holdings
5.65%
+0.45%
+9.52%
5.52B
Financial
AMC Entertainment
5.39%
-0.91%
-3.43%
1.15B
Communication Services
Riot Platforms
4.95%
+0.34%
+4.92%
2.99B
Financial
Plug Power
4.92%
-0.15%
+2.03%
2.50B
Industrials
Assertio Therapeutics
2.66%
-1.22%
-4.75%
88.49M
Healthcare
Blink Charging Co
5.05%
-0.03%
+3.85%
209.64M
Industrials
Block
4.60%
+0.02%
+4.69%
50.20B
Technology
Coherus Biosciences
2.60%
-1.27%
-4.44%
252.80M
Healthcare
Based on the activity of 720,935 active portfolios
Open your Smart Portfolio

VYNE Investor Analysis

VYNE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.4%
of VYNE holders
are under 35
Average Segment Performance
Average P/E Ratio57.88
Beta7.28
Dividend Yield5.79%
VYNE investors between 35–55

Between 35–55

3.4%
Last 30 days
Holdings Change
60.3%
of VYNE holders
are between 35–55
Average Segment Performance
Average P/E Ratio63.54
Beta11.04
Dividend Yield6.78%
VYNE investors over 55

Over 55

3.9%
Last 30 days
Holdings Change
24.3%
of VYNE holders
are over 55
Average Segment Performance
Average P/E Ratio54.91
Beta5.67
Dividend Yield5.91%
Overview of age group and performance of VYNE stock investors
See who invests in VYNE according to age group and performance.

FAQ

How many retail Investors hold VYNE?
<0.1% of TipRanks' retail investors hold VYNE in their portfolios.
    What is VYNE Investor Sentiment?
    VYNE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of VYNE in the last 7 days?
      ▼ 3.3% of TipRanks' retail investors changed their holding of VYNE in the last 7 days.
        What percentage of retail investors changed their holding of VYNE in the last 30 days?
        ▼ 4.8% of TipRanks' retail investors changed their holding of VYNE in the last 30 days.
          What is the average age of retail investors who hold VYNE?
          The average age of VYNE Holders is between 35–55.
            What other stocks have VYNE investors also bought?
            VYNE Investors also bought DKNG, CHPT, MARA, AMC, RIOT, PLUG, ASRT, BLNK, SQ, CHRS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Labs
              ALNYAlnylam Pharma
              ATECAlphatec Holdings
              NOTVInotiv
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis